DUBLIN, Feb 21, 2017 /PRNewswire/ --
Research and Markets has announced the addition of the "Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets" report to their offering.
The global market for gastrointestinal disorder therapeutics and diagnostics reached $49.6 billion in 2015. This market is expected to grow from nearly $51.8 billion in 2016 to $63.8 billion in 2021 at a compound annual growth rate of 4.3% from 2016-2021.
This report provides an overview of the global markets for gastrointestinal therapeutics and diagnostics. It provides analyses of global market trends, with data from 2015, estimates for 2016, and projections of CAGRs through 2021. It also analyses of therapeutics currently on the market as well as potential products and classes of products that are likely to have a significant impact.
This report is designed to provide an in-depth look at the therapeutic and diagnostic options of various gastrointestinal disorders. The geographic scope of the report is global, with particular emphasis on the key markets such as the U.S. and the European Union Five (EU5). The estimated market data is also global in nature, with geographic segments such as the U.S., EU and Rest of the World (ROW). The report provides a brief overview of the gastrointestinal system, which provides an introduction to the disorders of the gastrointestinal system; cites risk factors, where applicable; presents current pharmaceutical treatments, market size and key market participants (both prescription and OTC); and presents potential treatments in R&D, potential market size and future market entrants.
- Allergan Plc
- Ardelyx Inc.
- Astellas Pharma Inc.
- Celgene Corp.
- Clovis Oncology
- Daewoong Pharmaceutical Co., Ltd.
- ELI Lilly And Company
- Horizon Pharma Plc
- Merck & Co.
- Merrimack Pharmaceuticals Inc.
- New Link Genetics
- Otsuka Holdings Co. Ltd.
- Pfizer Inc.
- Sucampo Pharmaceuticals Inc.
- Synergy Pharmaceuticals Inc.
- Synthetic Biologics
- Taiho Pharmaceutical Co., Ltd.
- Takeda Pharmaceuticals
- Valeant Pharmaceuticals
Key Topics Covered:
1: Introduction - Complimentary
2: Executive Summary
5: Prescription Therapy Market
6: Otc Therapy Market
7: Diagnostics And Devices Market
8: Gastrointestinal Product Pipeline
10: Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/gzq3cr/gastrointestinal
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets